Compare TTEC & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | ARAY |
|---|---|---|
| Founded | 1982 | 1990 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 100.5M |
| IPO Year | N/A | N/A |
| Metric | TTEC | ARAY |
|---|---|---|
| Price | $2.22 | $0.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $3.50 | $3.50 |
| AVG Volume (30 Days) | 320.5K | ★ 959.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.12 | $0.50 |
| 52 Week High | $5.60 | $2.32 |
| Indicator | TTEC | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 26.75 | 22.88 |
| Support Level | $2.12 | $0.50 |
| Resistance Level | $3.08 | $0.58 |
| Average True Range (ATR) | 0.23 | 0.06 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 7.79 | 3.92 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.